KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Biogen (BIIB) Long-Term Debt Repayments (2017 - 2025)

Historic Long-Term Debt Repayments for Biogen (BIIB) over the last 10 years, with Q2 2025 value amounting to $1.8 billion.

  • Biogen's Long-Term Debt Repayments rose 60000.0% to $1.8 billion in Q2 2025 from the same period last year, while for Dec 2025 it was $1.8 billion, marking a year-over-year increase of 16923.08%. This contributed to the annual value of $1.8 billion for FY2025, which is 16923.08% up from last year.
  • As of Q2 2025, Biogen's Long-Term Debt Repayments stood at $1.8 billion, which was up 60000.0% from $250.0 million recorded in Q2 2024.
  • In the past 5 years, Biogen's Long-Term Debt Repayments registered a high of $1.8 billion during Q2 2025, and its lowest value of -$1.0 billion during Q4 2022.
  • Its 5-year average for Long-Term Debt Repayments is $321.0 million, with a median of $209.6 million in 2021.
  • In the last 5 years, Biogen's Long-Term Debt Repayments plummeted by 48952.94% in 2022 and then skyrocketed by 60000.0% in 2025.
  • Quarter analysis of 5 years shows Biogen's Long-Term Debt Repayments stood at -$170.0 million in 2021, then plummeted by 489.53% to -$1.0 billion in 2022, then surged by 164.86% to $650.0 million in 2023, then crashed by 61.54% to $250.0 million in 2024, then soared by 600.0% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q2 2025, $250.0 million for Q2 2024, and $400.0 million during Q1 2024.